ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 609,15
-0,69%
Dow Jones
39 157,62
0,12%
DAX
18 155,24
-0,04%
Brent Oil
84,61
0,50%
Bitcoin
60 967,60
-1,36%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. AlloVir Inc (ALVR)

  7. AlloVir Inc (ALVR) Actualités

ALVR

AlloVir (ALVR)

AlloVir Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ALVR
DateHeureSourceTitreSymboleSociété
11/06/202423h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALVRAlloVir Inc
07/06/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
22/05/202402h00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
13/05/202422h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ALVRAlloVir Inc
14/03/202411h10PR Newswire (US)Class Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:ALVRAlloVir Inc
07/03/202411h45PR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir, Inc. Lawsuit - ALVRNASDAQ:ALVRAlloVir Inc
15/02/202422h30Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:ALVRAlloVir Inc
09/02/202411h45PR Newswire (US)Shareholders that lost money on AlloVir, Inc.(ALVR) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:ALVRAlloVir Inc
02/02/202411h45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of AlloVir, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2024 - (NASDAQ: ALVR)NASDAQ:ALVRAlloVir Inc
09/01/202418h32Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ALVRAlloVir Inc
09/01/202418h29Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ALVRAlloVir Inc
05/01/202412h14IH Market NewsWall Street Highlights: Google Rejects Union Negotiations, Exxon Mobil Announces $2.5 Billion Accounting Write-Down in CaliforniaNASDAQ:ALVRAlloVir Inc
22/12/202313h00GlobeNewswire Inc.AlloVir Provides Updates on Phase 3 Clinical Development Program for Posoleucel, an Allogeneic Virus-Specific T Cell TherapyNASDAQ:ALVRAlloVir Inc
16/11/202313h00Business WireAlloVir to Present at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:ALVRAlloVir Inc
02/11/202312h00Business WireAlloVir Reports Third Quarter 2023 Financial ResultsNASDAQ:ALVRAlloVir Inc
28/08/202313h00Business WireAlloVir to Present at Upcoming Investor ConferencesNASDAQ:ALVRAlloVir Inc
03/08/202313h00Business WireAlloVir Reports Second Quarter 2023 Financial ResultsNASDAQ:ALVRAlloVir Inc
12/07/202313h41IH Market NewsWednesday’s Wall Street Highlights: Nvidia, VMware, Alphabet, Coty, IBM, and moreNASDAQ:ALVRAlloVir Inc
26/06/202322h14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ALVRAlloVir Inc
22/06/202323h16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ALVRAlloVir Inc
22/06/202303h20Business WireAlloVir Announces Pricing of Public Offering of Common StockNASDAQ:ALVRAlloVir Inc
21/06/202323h01Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ALVRAlloVir Inc
21/06/202322h18Business WireAlloVir Announces Proposed Public Offering of Common StockNASDAQ:ALVRAlloVir Inc
13/06/202323h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALVRAlloVir Inc
09/06/202322h22Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:ALVRAlloVir Inc
05/06/202313h00Business WireAlloVir Presents Positive Final Results From A Phase 2 Randomized, Placebo-Controlled Trial Evaluating Posoleucel Treatment of BK Infection in Kidney Transplant Recipients at the American Transplant Congress (ATC 2023)NASDAQ:ALVRAlloVir Inc
16/05/202313h00Business WireAlloVir Announces Appointment of Cintia Piccina, PharmD, MBA, as Chief Commercial OfficerNASDAQ:ALVRAlloVir Inc
04/05/202322h02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ALVRAlloVir Inc
04/05/202313h00Business WireAlloVir Reports First Quarter 2023 Financial ResultsNASDAQ:ALVRAlloVir Inc
01/05/202322h12Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ALVRAlloVir Inc
 Showing the most relevant articles for your search:NASDAQ:ALVR

Dernières Valeurs Consultées

NYSE
NX
Quanex
TG
A1ZYTP
APT Pipelines
NASDAQ
SCMF
Southern Community Financial
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés